Biotechnology Market Research Reports
Sort By
| Title | Published | Price | Buy Now |
|---|---|---|---|
| CCR5 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CCR5 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CCR5 Inhibitor development. The report provides detailed coverage of... |
Jan 2019 | $ 1250 | |
| CD 19 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 19 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 19 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 | |
| CD 33 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 33 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 33 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 | |
| CD 40 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD 40 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD 40 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 | |
| CD152 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"CD152 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD152 Inhibitor development. The report provides detailed coverage ... |
Jan 2019 | $ 1250 | |
| CD40 Agonist - Pipeline Insight, 2019
By Delve Insight
"CD40 Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "CD40 Agonist development. The report provides detailed coverage of the... |
Jan 2019 | $ 1250 | |
| Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cell Division Cycle 7 (CDC7) Related Protein Kinase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cell Division Cycle 7... |
Jan 2019 | $ 1250 | |
| Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Checkpoint Kinase 1 (Chk1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Checkpoint Kinase 1 (Chk1) Inhibitor developme... |
Jan 2019 | $ 1250 | |
| Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Checkpoint Kinase 2 (Chk2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Checkpoint Kinase 2 (Chk2) Inhibitor developme... |
Jan 2019 | $ 1250 | |
| Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclin-Dependent Kinase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclin-Dependent Kinase Inhibitor development. Th... |
Jan 2019 | $ 1250 | |
| Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclin-Dependent Kinase 1 (CDK1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclin-Dependent Kinase 1 (CDK1) Inhibit... |
Jan 2019 | $ 1250 | |
| Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclin-Dependent Kinase 2 (CDK2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclin-Dependent Kinase 2 (CDK2) Inhibit... |
Jan 2019 | $ 1250 | |
| Cyclophilin Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cyclophilin Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cyclophilin Inhibitor development. The report provides detail... |
Jan 2019 | $ 1250 | |
| Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cystic Fibrosi... |
Jan 2019 | $ 1250 | |
| Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Cytochrome P450 17 (CYP17) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Cytochrome P450 17 (CYP17) Inhibitor developme... |
Jan 2019 | $ 1250 | |
| Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Diglyceride Acyltransferase (DGAT) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Diglyceride Acyltransferase (DGAT) Inh... |
Jan 2019 | $ 1250 | |
| Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Dihydroorotate Dehydrogenase (DHODH) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Dihydroorotate Dehydrogenase (DHODH)... |
Jan 2019 | $ 1250 | |
| DNA Methyltransferase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"DNA Methyltransferase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "DNA Methyltransferase Inhibitor development. The re... |
Jan 2019 | $ 1250 | |
| DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"DNA-Dependent RNA Polymerase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "DNA-Dependent RNA Polymerase Inhibitor devel... |
Jan 2019 | $ 1250 | |
| DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2019
By Delve Insight
"DP2 Receptor (G Protein-Coupled Receptor 44 or Chemoattractant Receptor-Homologous Molecule On Th2 Cells (CRTH2)) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeut... |
Jan 2019 | $ 1250 | |
| Eg5 Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Eg5 Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Eg5 Inhibitor development. The report provides detailed coverage of t... |
Jan 2019 | $ 1250 | |
| Elastase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Elastase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Elastase Inhibitor development. The report provides detailed cov... |
Jan 2019 | $ 1250 | |
| Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Endothelin Receptor (ET) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Endothelin Receptor (ET) Antagonist development... |
Jan 2019 | $ 1250 | |
| Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Endothelin Receptor A (ETA) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Endothelin Receptor A (ETA) Antagonist devel... |
Jan 2019 | $ 1250 | |
| Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Enhancer of zeste homolog 2 (EZH2) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Enhancer of zeste homolog 2 (EZH2) Inh... |
Jan 2019 | $ 1250 |